Europe Embolization Agents Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Coils, Plugs, Beads/ Particles, Detachable Balloons, Glue, Sponge, Liquid Embolics, Sclerosants, Precipitating Agents, and Others), Application (Oncology, Neurology, Urology, Cardiology, Peripheral Vascular Diseases, and Others), and End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Others) 

No. of Pages: 175    |    Report Code: TIPRE00026128    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Embolization Agents Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Embolization Agents Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Embolization Agents Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 Rising prevalence of vascular diseases.
  • 5.1.3 Advancements in minimally invasive procedures.
  • 5.1.4 Growing demand for targeted cancer therapies.
5.2 Market Opportunities
  • 5.2.1
  • 5.2.2 Development of novel embolization products.
  • 5.2.3 Expansion into emerging markets.
  • 5.2.4 Partnerships with healthcare facilities for training.
5.3 Future Trends
  • 5.3.1
  • 5.3.2 Increased use of biocompatible materials.
  • 5.3.3 Focus on personalized treatment approaches.
  • 5.3.4 Innovations in imaging techniques for procedures.
5.4 Impact of Drivers and Restraints

6. Europe Embolization Agents Market Regional Analysis

6.1 Europe Embolization Agents Market Overview
6.2 Europe Embolization Agents Market Revenue 2019-2028 (US$ Million)
6.3 Europe Embolization Agents Market Forecast Analysis

7. Europe Embolization Agents Market Analysis – by Product

7.1 Coils
  • 7.1.1 Overview
  • 7.1.2 Coils: Europe Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Plugs
  • 7.2.1 Overview
  • 7.2.2 Plugs: Europe Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Beads/Particles
  • 7.3.1 Overview
  • 7.3.2 Beads/Particles: Europe Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Detachable Balloons
  • 7.4.1 Overview
  • 7.4.2 Detachable Balloons: Europe Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Glue
  • 7.5.1 Overview
  • 7.5.2 Glue: Europe Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Sponge
  • 7.6.1 Overview
  • 7.6.2 Sponge: Europe Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Liquid Embolics
  • 7.7.1 Overview
  • 7.7.2 Liquid Embolics: Europe Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Sclerosants
  • 7.8.1 Overview
  • 7.8.2 Sclerosants: Europe Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Precipitating Agents
  • 7.9.1 Overview
  • 7.9.2 Precipitating Agents: Europe Embolization Agents Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Embolization Agents Market Analysis – by Application

8.1 Oncology
  • 8.1.1 Overview
  • 8.1.2 Oncology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Neurology
  • 8.2.1 Overview
  • 8.2.2 Neurology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Urology
  • 8.3.1 Overview
  • 8.3.2 Urology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Cardiology
  • 8.4.1 Overview
  • 8.4.2 Cardiology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Peripheral Vascular Diseases
  • 8.5.1 Overview
  • 8.5.2 Peripheral Vascular Diseases: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Embolization Agents Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Peripheral Vascular Diseases: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Cardiac Centers
  • 9.2.1 Overview
  • 9.2.2 Peripheral Vascular Diseases: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Ambulatory Surgical Centers
  • 9.3.1 Overview
  • 9.3.2 Peripheral Vascular Diseases: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Embolization Agents Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Embolization Agents Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 Europe Embolization Agents Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 UK: Europe Embolization Agents Market Breakdown, by Product
    • 10.1.1.1.2 UK: Europe Embolization Agents Market Breakdown, by Application
    • 10.1.1.1.3 UK: Europe Embolization Agents Market Breakdown, by End User
  • 10.1.1.2 Germany: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Embolization Agents Market Breakdown, by Product
    • 10.1.1.2.2 Germany: Europe Embolization Agents Market Breakdown, by Application
    • 10.1.1.2.3 Germany: Europe Embolization Agents Market Breakdown, by End User
  • 10.1.1.3 France: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 France: Europe Embolization Agents Market Breakdown, by Product
    • 10.1.1.3.2 France: Europe Embolization Agents Market Breakdown, by Application
    • 10.1.1.3.3 France: Europe Embolization Agents Market Breakdown, by End User
  • 10.1.1.4 Russia: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Embolization Agents Market Breakdown, by Product
    • 10.1.1.4.2 Russia: Europe Embolization Agents Market Breakdown, by Application
    • 10.1.1.4.3 Russia: Europe Embolization Agents Market Breakdown, by End User
  • 10.1.1.5 Italy: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Embolization Agents Market Breakdown, by Product
    • 10.1.1.5.2 Italy: Europe Embolization Agents Market Breakdown, by Application
    • 10.1.1.5.3 Italy: Europe Embolization Agents Market Breakdown, by End User
  • 10.1.1.6 Rest of Europe: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Embolization Agents Market Breakdown, by Product
    • 10.1.1.6.2 Rest of Europe: Europe Embolization Agents Market Breakdown, by Application
    • 10.1.1.6.3 Rest of Europe: Europe Embolization Agents Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Embolization Agents Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Boston Scientific Corporation
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Cook Medical LLC
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 DePuy Synthes
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 KANEKA CORPORATION
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Medtronic
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Merit Medical Systems Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Penumbra, Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Stryker Corporation
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Terumo Corporation
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

  1. Abbott
  2. Boston Scientific Corporation
  3. Cook Medical LLC
  4. DePuy Synthes
  5. KANEKA CORPORATION
  6. Medtronic
  7. Merit Medical Systems Inc
  8. Penumbra, Inc.
  9. Stryker Corporation
  10. Terumo Corporation
europe-embolization-agents-market